Literature DB >> 2743843

Effects of NC-1300, a gastric proton pump inhibitor, on healing of acetic acid-induced gastric ulcers in rats.

S Okabe1, H Miyake, S Yamasaki.   

Abstract

Effects of NC-1300 (a gastric proton pump inhibitor) on healing of experimental chronic gastric ulcers induced in rats were studied. Gastric ulcers were induced by the submucosal injection of 20% acetic acid (0.03 ml) into the antral-oxyntic border of the anterior wall of male Donryu rats (260-280 g). The healing of acetic acid ulcers was delayed by the daily subcutaneous administration of indomethacin (1 mg/kg) for two or four weeks after ulceration. Aggravation of healed ulcers was evoked by subcutaneous administration of indomethacin (1 mg/kg) once daily for four weeks to rats with four-week-old ulcers. Oral administration of NC-1300 (10, 30, or 100 mg/kg) once daily for two or four weeks after ulceration dose-dependently accelerated both natural and delayed healing of acetic acid ulcers. When the period of administration was extended from two to four weeks, the ED50 values (the dose reducing the ulcerated area by 50%) were decreased from 36.5 to 13.5 mg/kg in natural healing and from 76.0 to 23.0 mg/kg in delayed healing. Aggravation of four-week-old ulcers by indomethacin was significantly prevented by daily administration of NC-1300 (30 or 100 mg/kg) for four weeks. Acetic acid ulcers that were healed with NC-1300 given for four weeks after ulceration remained healed for four to eight weeks after the cessation of drug administration. A single administration of NC-1300 to normal rats and repeated administration of NC-1300 to rats with acetic acid ulcers for four weeks after ulceration caused the same degree of inhibition of gastric acid secretion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2743843     DOI: 10.1007/bf01536370

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Chronicity of acetic acid ulcer in the rat stomach.

Authors:  S Okabe; C J Pfeiffer
Journal:  Am J Dig Dis       Date:  1972-07

2.  A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing.

Authors:  K Takagi; S Okabe; R Saziki
Journal:  Jpn J Pharmacol       Date:  1969-09

3.  Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor.

Authors:  S Okabe; E Higaki; T Higuchi; M Sato; K Hara
Journal:  Jpn J Pharmacol       Date:  1986-02

4.  Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.

Authors:  S J Konturek; T Radecki; I Piastucki; D Drozdowicz
Journal:  Digestion       Date:  1987       Impact factor: 3.216

5.  Cytoprotective effects of NC-1300 and omeprazole on Hcl . ethanol-induced gastric lesions in rats.

Authors:  S Okabe; H Miyake; Y Awane
Journal:  Jpn J Pharmacol       Date:  1986-09

6.  Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo.

Authors:  H Larsson; H Mattson; G Sundell; E Carlsson
Journal:  Scand J Gastroenterol Suppl       Date:  1985

7.  Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats.

Authors:  S Okabe; K Takeuchi; H Kunimi; M Kanno; M Kawashima
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

8.  Sucralfate protection of the gastric mucosa against ethanol-induced injury: a prostaglandin-mediated process?

Authors:  D Hollander; A Tarnawski; H Gergely; R D Zipser
Journal:  Scand J Gastroenterol Suppl       Date:  1984

9.  Effects of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on gastric secretion and various gastric lesions induced in rats.

Authors:  S Okabe; H Jino; A Nishida
Journal:  Jpn J Pharmacol       Date:  1986-02

10.  Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial.

Authors:  F Martin; A Farley; M Gagnon; D Bensemana
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.